TF–RBP–AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers

Aberrant alternative splicing (AS) is increasingly linked to cancer; however, how AS contributes to cancer development still remains largely unknown. AS events (ASEs) are largely regulated by RNA-binding proteins (RBPs) whose ability can be modulated by a variety of genetic and epigenetic mechanisms...

Full description

Bibliographic Details
Main Authors: Meng He, Fuyan Hu
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/16/8789
_version_ 1797523608460853248
author Meng He
Fuyan Hu
author_facet Meng He
Fuyan Hu
author_sort Meng He
collection DOAJ
description Aberrant alternative splicing (AS) is increasingly linked to cancer; however, how AS contributes to cancer development still remains largely unknown. AS events (ASEs) are largely regulated by RNA-binding proteins (RBPs) whose ability can be modulated by a variety of genetic and epigenetic mechanisms. In this study, we used a computational framework to investigate the roles of transcription factors (TFs) on regulating RBP-AS interactions. A total of 6519 TF–RBP–AS triplets were identified, including 290 TFs, 175 RBPs, and 16 ASEs from TCGA–KIRC RNA sequencing data. TF function categories were defined according to correlation changes between RBP expression and their targeted ASEs. The results suggested that most TFs affected multiple targets, and six different classes of TF-mediated transcriptional dysregulations were identified. Then, regulatory networks were constructed for TF–RBP–AS triplets. Further pathway-enrichment analysis showed that these TFs and RBPs involved in triplets were enriched in a variety of pathways that were associated with cancer development and progression. Survival analysis showed that some triplets were highly associated with survival rates. These findings demonstrated that the integration of TFs into alternative splicing regulatory networks can help us in understanding the roles of alternative splicing in cancer.
first_indexed 2024-03-10T08:45:23Z
format Article
id doaj.art-fc72241a4b0044168b15751f194221cb
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T08:45:23Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-fc72241a4b0044168b15751f194221cb2023-11-22T08:00:38ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-08-012216878910.3390/ijms22168789TF–RBP–AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic BiomarkersMeng He0Fuyan Hu1Department of Statistics, School of Science, Wuhan University of Technology, 122 Luoshi Road, Wuhan 430070, ChinaDepartment of Statistics, School of Science, Wuhan University of Technology, 122 Luoshi Road, Wuhan 430070, ChinaAberrant alternative splicing (AS) is increasingly linked to cancer; however, how AS contributes to cancer development still remains largely unknown. AS events (ASEs) are largely regulated by RNA-binding proteins (RBPs) whose ability can be modulated by a variety of genetic and epigenetic mechanisms. In this study, we used a computational framework to investigate the roles of transcription factors (TFs) on regulating RBP-AS interactions. A total of 6519 TF–RBP–AS triplets were identified, including 290 TFs, 175 RBPs, and 16 ASEs from TCGA–KIRC RNA sequencing data. TF function categories were defined according to correlation changes between RBP expression and their targeted ASEs. The results suggested that most TFs affected multiple targets, and six different classes of TF-mediated transcriptional dysregulations were identified. Then, regulatory networks were constructed for TF–RBP–AS triplets. Further pathway-enrichment analysis showed that these TFs and RBPs involved in triplets were enriched in a variety of pathways that were associated with cancer development and progression. Survival analysis showed that some triplets were highly associated with survival rates. These findings demonstrated that the integration of TFs into alternative splicing regulatory networks can help us in understanding the roles of alternative splicing in cancer.https://www.mdpi.com/1422-0067/22/16/8789alternative splicingRNA-binding proteintranscription factorTF–RBP–AS tripletsregulation mechanism
spellingShingle Meng He
Fuyan Hu
TF–RBP–AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers
International Journal of Molecular Sciences
alternative splicing
RNA-binding protein
transcription factor
TF–RBP–AS triplets
regulation mechanism
title TF–RBP–AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers
title_full TF–RBP–AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers
title_fullStr TF–RBP–AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers
title_full_unstemmed TF–RBP–AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers
title_short TF–RBP–AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers
title_sort tf rbp as triplet analysis reveals the mechanisms of aberrant alternative splicing events in kidney cancer implications for their possible clinical use as prognostic and therapeutic biomarkers
topic alternative splicing
RNA-binding protein
transcription factor
TF–RBP–AS triplets
regulation mechanism
url https://www.mdpi.com/1422-0067/22/16/8789
work_keys_str_mv AT menghe tfrbpastripletanalysisrevealsthemechanismsofaberrantalternativesplicingeventsinkidneycancerimplicationsfortheirpossibleclinicaluseasprognosticandtherapeuticbiomarkers
AT fuyanhu tfrbpastripletanalysisrevealsthemechanismsofaberrantalternativesplicingeventsinkidneycancerimplicationsfortheirpossibleclinicaluseasprognosticandtherapeuticbiomarkers